BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults

Neurobiology of Learning and Memory

Volumn 110, Issue , 2014, Pages 1-7

  Stuart, Kimberley ^a   Summers, Mathew James ^a   Valenzuela, Michael J ^b   Vickers, James C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ageing; BDNF; Cognition; COMT; LEQ; Memory

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BDNF GENE; COGNITION; COMT GENE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EPISODIC MEMORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HEARING; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; MIDDLE AGED; NORMAL HUMAN; PERSONAL EXPERIENCE; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VISION; VISUAL MEMORY; AGING; GENETICS; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY;

AGED; AGING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; COGNITION; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84896720429     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2014.01.013     Document Type: Article

References (64)

1. Ahmed S., Mitchell J., Arnold R., Dawson K., Nestor P., Hodges J. Memory complaints in mild cognitive impairment, worried well, and semantic dementia patients. Alzheimer's Disease and Associated Disorders 2008, 22:227-235.
2. Barnett J.H., Barnett L.S., Munafo M.R. Meta-analysis of the cognitive effects of the Catechol-O-methyltransferase Gene Val158/108Met polymorphism. Biological Psychiatry 2008, 64:137-144.
3. Barnett J., Jones P., Robbins T., Muller U. Effects of Catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin card sorting tests in schizophrenia and healthy controls. Molecular Psychiatry 2007, 12:502-509.
4. Bath K., Lee F. Variant BDNF (Val66Met) impact on brain structure and function. Cognitive, Affective & Behavioural Neuroscience 2006, 6:79-85.
5. Cambridge automated neuropsychological test assessment battery 2004, Cambridge Cognition, Cambridge Cognition Ltd., Cambridge. third ed.
6. Benjamin S., McQuoid D., Potter G., Payne M., MacFall J., Steffens D., et al. The BDNF Val66Met polymorphism, hippocampal volume and cognitive function in geriatric depression. Geriatric Psychiatry 2010, 18:323-333.
7. Casey B.J., Glatt C.E., Tottenham N., Soliman F., Bath K., Amso D., et al. BDNF as a model system for examining gene by environment interactions across development. Neuroscience 2009, 24:108-120.
8. de Frias C., Annerbrink K. COMT gene polymorphisms is associated with declarative memory in adulthood and old age. Behavioural Genetics 2004, 34:533-539.
9. de Gues J.C., Wright M.J., Martin N.G., Boomsma D.I. Genetics of brain function and cognition. Behavior Genetics 2001, 31:489-495.
10. Dempster E., Toulopoulu T., McDonald C., Bramon E., Walshe M., Filbey F., et al. Association between BDNF val66met genotype and episodic memory. Neuropsychiatric Genetics 2005, 134:73-75.
11. Dennis N., Cabeza R., Need A., Waters-Meteniew S., Goldstein D., LaBar K. Brain-derived neurotrophic factor Val66Met polymorphism and hippocampal activation during episodic encoding and retrieval tasks. Hippocampus 2011, 21:980-989.
12. Dennis N., Need A., LaBar K., Waters-Metenier S., Cirulli E., Kragel J., et al. COMT Val158Met genotype affects neural but not cognitive processing in healthy individuals. Cerebral Cortex 2009, 20:672-683.
13. Dickinson D., Elvevag B. Genes, cognition and brain through a COMT lens. Neuroscience 2009, 164:72-87.
14. Dixon A., Liang L., Moffatt M., Chen W., Heath S., Wong K., et al. A genome-wide association study of global gene expression. Nature Genetics 2007, 39:1202-1207.
15. Donnel A., Pliskin N., Holdnack J., Axelrod B., Randolph C. Rapidly-administered short forms of the Wechsler adult intelligence scale-3rd edition. Archives of Clinical Neuropsychology 2007, 22:917-924.
16. Egan M., Goldberg T., Kolachana B., Callicott J., Mazzanti C., Straub R., et al. The effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6917-6922.
17. Egan M., Kojima M., Callicott J., Goldberg T., Kolachana B., Bertolino A., et al. The BDNF Val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
18. Erikson K., Voss M., Prakash R., Basak C., Szabo A., Chaddock A., et al. Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:3017-3022.
19. Finkel D., Reynolds C.A., McArdle J.J., Pedersen N.L. The longitudinal relationship between processing speed and cognitive ability: Genetic and environmental influences. Behavior Genetics 2005, 35:535-549.
20. Forlenza O., Diniz B., Teixeira A., Ojopi E., Talib L., Mendonca V., et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World Journal of Biological Psychiatry 2010, 11:774-780.
21. Fowler K.S., Saling M.M., Conway E.L., Semple J.M., Louis W.J. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society 2002, 8:58-71.
22. Fray P., Robbins T., Sahakian B. Neuropsychiatric applications of CANTAB. International Journal of Geriatric Psychiatric 1996, 11:329-336.
23. Ganguly K., Poo M. Activity-dependent neural plasticity from bench to bedside. Neuron 2013, 80:729-741.
24. Gong P., Zheng Z., Chi W., Lei X., Wu X., Chen D., et al. An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories. Journal of Molecular Neuroscience 2012, 46:352-361.
25. Gratacos M., Gonzales J.R., de Mercader J.M., Cid R., Urretavizcaya M., Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry 2007, 7:911-922.
26. Hariri A., Goldberg T., Mattay V., Kolachana B., Callicott J., Egan M., et al. Brain-derived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience 2003, 23:6690-6694.
27. Harris S., Fox H., Wright A., Hayward C., Starr J., Whalley L., et al. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry 2006, 11:505-513.
28. Harris S.E., Deary I.J. The genetics of cognitive ability and cognitive ageing in healthy older people. Trends in Cognitive Sciences 2011, 15:388-394.
29. Hashimoto R., Moriguchi Y., Yamashita F., Mori T., Nemoto K., Okada T., et al. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neuroscience Research 2008, 61:360-367.
30. Kambeitz J.P., Bhattacharyya S., Kambeitz-Ilankovic L.M., Valli I., Collier D.A., McGuire P. Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: A meta-analysis. Neuroscience Biobehavioural Review 2012, 36:2165-2177.
31. Koppel J., Goldberg T. The genetics of episodic memory. Cognitive Psychology 2009, 14:356-376.
32. Laing K., Mitchell D., Wersching H., Czira M., Berger K., Baune B. Brain-derived neurotrophic factor gene: A gender-specific role in cognitive function during normal cognitive aging of the MEMO study. Age 2012, 34:1011-1022.
33. Lajin B., Alachkar A., Hamzeh A., Michati R., Alhaj H. No association between val158met of the COMT gene and susceptibility to schizophrenia in the Syrian population. North American Journal of Medical Sciences 2011, 1:176-178.
34. Lessov-Schlagger C., Swan G., Reed T., Wolf P., Carmelli D. Longitudinal genetic analysis of executive function in elderly men. Neurobiology of Aging 2007, 28:1759-1768.
35. Lezak M.D., Howieson D.B., Bigler E.D., Tranel D. Neuropsychological assessment 2012, Oxford University Press, Oxford. 5th ed.
36. Mandolesi G., Menna E., Harauzov A., von Bartheld C.S., Caelo M., Maeffei L. A role for retinal brain-derived neurotrophic factor in ocular dominance plasticity. Current Biology 2005, 15:2119-2124.
37. 158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences 2003, 100:6186-6191.
38. Mattson M., Maudley S., Martin B. BDNF and 5-HT: A dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neuroscience 2004, 27:589-594.
39. Miller E., Cohen J. An intergrative theory of prefrontal cortex function. Annual Review of Neuroscience 2001, 24:167-202.
40. Miyajima F., Ollier W., Mayes A., Jackson A., Thacker N., Rabbitt P., et al. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes, Brain, and Behaviour 2008, 4:411-417.
41. Mizuno M., Yamada K., Olariu A., Nawa H., Naeshima T. Involvement of the brain-derived neurotrophic factor in spatial memory formation and maintenance in radial arm test in rats. Journal of Neuroscience 2000, 15:7116-7121.
42. Morris J.C., Price J.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. Journal of Molecular Neuroscience 2001, 17:101-118.
43. Nagel I., Chicherio C., Li S., von Oertzen T., Sandler T., Villringer A., et al. Human aging magnifies genetic effects on executive functioning and working memory. Frontiers in Human Neuroscience 2008, 2:1-8.
44. Nepal B., Ranmuthugala G., Brown L., Budge M. Modelling costs of dementia in Australia: Evidence, gaps, and needs. Australian Health review 2008, 32:479-487.
45. Raz N., Rodrigue K. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neuroscience and Biobehavioural Reviews 2006, 30:730-748.
46. Raz N., Rodrigue K., Kennedy K., Land S. Genetic and vascular modifiers of age-sensitive cognitive skills: Effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology 2009, 23:105-116.
47. Sambataro F., Murty V., Lemaitre H., Reed J., Das S., Callicott J., et al. BDNF modulates normal hippocampal ageing. Molecular Psychiatry 2010, 15:116-118.
48. Seeman T.E., Lusignolo T.M., Albert M., Berkman L. Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. Health Psychology 2001, 4:243-255.
49. Sheikha H., Hayden E., Kryski K., Smith H., Singha S. Genotyping the BDNF rs6265 polymorphism by one-step amplified refractory mutation system PCR. Psychiatry Genetics 2011, 3:109-112.
50. Starr J., Fox H., Harris S., Deary I., Whalley L. COMT genotype and cognitive ability: A longitudinal study. Neuroscience Letters 2007, 421:57-61.
51. Strauss J., Barr C.L., George C.J., Ryan C.M., King N., Shaikh S., et al. BDNF and COMT polymorphisms. NeuroMolecular Medicine 2004, 5:181-192.
52. Strauss E., Sherman S., Spreen O. A compendium of neuropsychological tests: Administration, norms, and commentary 2006, Oxford University Press, New York. 3rd ed.
53. Summers M.J., Saunders N.L., Valenzuela M.J., Summers J.J., Ritchie K., Robinson A., et al. The Tasmanian Healthy Brain Project (THBP): A prospective longitudinal examination of the effect of university-level education in older adults in preventing age-related cognitive decline and reducing the risk of dementia. International Psychogeriatrics 2013, 25:1145-1155.
54. Tierney M.C., Yao C., Kiss A., McDowell I. Neuropsychological tests predict incident Alzheimer disease after 5 and 10 years. Neurology 2005, 1853-1859.
55. Valenzuela M., Sachdev P. Brain reserve and cognitive decline: A non-parametric systematic review. Psychological Medicine 2006, 1065-1073.
56. Valenzuela M., Sachdev P. Assessment of complex mental activity across the lifespan: Development of the lifetime of experiences questionnaire. Psychological Medicine 2007, 37:1015-1025.
57. Valenzuela M., Sachdev P., Wen W., Chen X., Brodaty H. Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS ONE 2008, 3:2583-2589.
58. Valenzuela M.J., Leon I., Suo C., Piamba D.M., Kochan N., Brodaty H., Sachdev P. Cognitive lifestyle in older persons: the population-based Sydney Memory and Ageing Study. Journal of Alzheimer's Disease 2013, 36:87-97.
59. Vickers J.C., Riederer B.M., Marugg R.A., Buee-Sherrer V., Buee L., Delacourtes A., et al. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 1994, 62:1-13.
60. Weschler D. Weschler Test of Adult Reading (WTAR) 2001, Pearson, San Antonio, TX.
61. Witte V., Kurten J., Jansen S., Schirmacher A., Brand E., Sommer J., et al. Interaction of BDNF and COMT polymorphisms on paired-associative stimulation- induced cortical plasticity. The Journal of Neuroscience 2012, 32:4553-4561.
62. Wong J., Webster M.J., Cassano H., Weickert C.S. Changes in alternative brain-derived neurotrophic factor transcript expression in the developing human prefrontal cortex. European Journal of Neuroscience 2009, 29:1311-1322.
63. Zakzanis K. Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Archives of Clinical Neuropsychology 2011, 16:653-667.
64. Zdanys K.F., Kleiman T.G., Zhang H., Ozbay F., MacAvoy M.G., Gelernter J., et al. BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: An exploratory study. Journal of Alzheimer's disease 2009, 17:887-898.